Consensus statement on the management of patients with HCV infection in Romania
HCV direct-acting antivirals (DAAs) have made treatment easier for both patients and healthcare practitioners, but have also brought new challenges in terms of patient management and monitoring prior to, during, and after treatment. To sum up and unify the clinical experience of Romanian DAA prescri...
Gespeichert in:
| Veröffentlicht in: | Germs (Bucureşti) 2017-03, Vol.7 (1), p.32-39 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 39 |
|---|---|
| container_issue | 1 |
| container_start_page | 32 |
| container_title | Germs (Bucureşti) |
| container_volume | 7 |
| creator | Adrian, Streinu-Cercel |
| description | HCV direct-acting antivirals (DAAs) have made treatment easier for both patients and healthcare practitioners, but have also brought new challenges in terms of patient management and monitoring prior to, during, and after treatment.
To sum up and unify the clinical experience of Romanian DAA prescribing physicians, we have organized a Consensus Meeting in November 2016 in Bucharest, Romania.
The Consensus Meeting has provided expert answers to ten significant questions regarding HCV infection, namely: How do we diagnose patients with HCV infection? How do we stage liver disease in patients with HCV infection? How do we monitor patients with HCV infection prior to treatment? Which patients with HCV infection do we treat? When do we start treatment for HCV infection? What regimens do we use for treating HCV infection? How do we monitor patients with HCV infection during treatment? What adverse events should we expect during treatment of HCV infection and how do we prevent/manage them? How do we monitor patients with HCV infection after treatment? How do we expect the landscape of HCV to change in the following years? |
| doi_str_mv | 10.18683/germs.2017.1106 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5348215</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A512239466</galeid><sourcerecordid>A512239466</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3676-6ffba8071a21103a61b791f9a172551a52fea6709b6d7317e0b8be271a91029d3</originalsourceid><addsrcrecordid>eNptkt9rFDEQxxdRbKl990kCgvhyZ37s5seLUA5rhUJB1NeQ3Zvcpuwm5yZb8b_vXHvWO3HykGHymR8ZvlX1mtEl01KLDxuYxrzklKklY1Q-q045r_WCG6OeH_gn1XnOtxRNUyqVfFmdcC0E0zU9rW5WKWaIec4kF1dghFhIiqT0QEYX3WYf8WTrSkA3k1-h9ORq9YOE6KErAekQydeEeHCvqhfeDRnO9_dZ9f3y07fV1eL65vOX1cX1ohM4wkJ63zpNFXMcRxdOslYZ5o1jijcNcw334KSippVrJZgC2uoWOPKGUW7W4qz6-Fh3O7cjrDucbHKD3U5hdNNvm1ywxy8x9HaT7mwjas1ZgwXe7wtM6ecMudgx5A6GwUVIc7ZMa1pjayYQffsPepvmKeL3kDJcojXqL7VxA1jcTcK-3a6ovWgY58LUUiK1_A-FZw1j6FIEHzB-lPDuIKEHN5Q-p2He7T0fg_QR7KaU8wT-aRmM2gfB2AfB2J1g7E4wmPLmcIlPCX_kIe4BdVC5rg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1892666657</pqid></control><display><type>article</type><title>Consensus statement on the management of patients with HCV infection in Romania</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Adrian, Streinu-Cercel</creator><creatorcontrib>Adrian, Streinu-Cercel ; Consensus Statement on HCV Infection in Romania Working Group ; Consensus Statement on HCV Infection in Romania Working Group</creatorcontrib><description>HCV direct-acting antivirals (DAAs) have made treatment easier for both patients and healthcare practitioners, but have also brought new challenges in terms of patient management and monitoring prior to, during, and after treatment.
To sum up and unify the clinical experience of Romanian DAA prescribing physicians, we have organized a Consensus Meeting in November 2016 in Bucharest, Romania.
The Consensus Meeting has provided expert answers to ten significant questions regarding HCV infection, namely: How do we diagnose patients with HCV infection? How do we stage liver disease in patients with HCV infection? How do we monitor patients with HCV infection prior to treatment? Which patients with HCV infection do we treat? When do we start treatment for HCV infection? What regimens do we use for treating HCV infection? How do we monitor patients with HCV infection during treatment? What adverse events should we expect during treatment of HCV infection and how do we prevent/manage them? How do we monitor patients with HCV infection after treatment? How do we expect the landscape of HCV to change in the following years?</description><identifier>ISSN: 2248-2997</identifier><identifier>EISSN: 2248-2997</identifier><identifier>DOI: 10.18683/germs.2017.1106</identifier><identifier>PMID: 28331840</identifier><language>eng</language><publisher>Romania: Asociatia pentru Cresterea Vizibilitatii Cercetarii Stiintifice (ACVCS)</publisher><subject>Colleges & universities ; Drug therapy ; Evaluation ; Hepatitis C ; Hospitals ; Infections ; Infectious diseases ; Laboratories ; Liver cancer ; Liver diseases ; Medical care quality ; Medical imaging ; Medicine ; Patients ; Pharmacy ; Review ; Ultrasonic imaging</subject><ispartof>Germs (Bucureşti), 2017-03, Vol.7 (1), p.32-39</ispartof><rights>COPYRIGHT 2017 Asociatia pentru Cresterea Vizibilitatii Cercetarii Stiintifice (ACVCS)</rights><rights>Copyright European HIV/AIDS and Infectious Diseases Academy Mar 2017</rights><rights>GERMS 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3676-6ffba8071a21103a61b791f9a172551a52fea6709b6d7317e0b8be271a91029d3</citedby><orcidid>0000-0001-6382-5067</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348215/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348215/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27926,27927,53793,53795</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28331840$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adrian, Streinu-Cercel</creatorcontrib><creatorcontrib>Consensus Statement on HCV Infection in Romania Working Group</creatorcontrib><creatorcontrib>Consensus Statement on HCV Infection in Romania Working Group</creatorcontrib><title>Consensus statement on the management of patients with HCV infection in Romania</title><title>Germs (Bucureşti)</title><addtitle>Germs</addtitle><description>HCV direct-acting antivirals (DAAs) have made treatment easier for both patients and healthcare practitioners, but have also brought new challenges in terms of patient management and monitoring prior to, during, and after treatment.
To sum up and unify the clinical experience of Romanian DAA prescribing physicians, we have organized a Consensus Meeting in November 2016 in Bucharest, Romania.
The Consensus Meeting has provided expert answers to ten significant questions regarding HCV infection, namely: How do we diagnose patients with HCV infection? How do we stage liver disease in patients with HCV infection? How do we monitor patients with HCV infection prior to treatment? Which patients with HCV infection do we treat? When do we start treatment for HCV infection? What regimens do we use for treating HCV infection? How do we monitor patients with HCV infection during treatment? What adverse events should we expect during treatment of HCV infection and how do we prevent/manage them? How do we monitor patients with HCV infection after treatment? How do we expect the landscape of HCV to change in the following years?</description><subject>Colleges & universities</subject><subject>Drug therapy</subject><subject>Evaluation</subject><subject>Hepatitis C</subject><subject>Hospitals</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Laboratories</subject><subject>Liver cancer</subject><subject>Liver diseases</subject><subject>Medical care quality</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Patients</subject><subject>Pharmacy</subject><subject>Review</subject><subject>Ultrasonic imaging</subject><issn>2248-2997</issn><issn>2248-2997</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkt9rFDEQxxdRbKl990kCgvhyZ37s5seLUA5rhUJB1NeQ3Zvcpuwm5yZb8b_vXHvWO3HykGHymR8ZvlX1mtEl01KLDxuYxrzklKklY1Q-q045r_WCG6OeH_gn1XnOtxRNUyqVfFmdcC0E0zU9rW5WKWaIec4kF1dghFhIiqT0QEYX3WYf8WTrSkA3k1-h9ORq9YOE6KErAekQydeEeHCvqhfeDRnO9_dZ9f3y07fV1eL65vOX1cX1ohM4wkJ63zpNFXMcRxdOslYZ5o1jijcNcw334KSippVrJZgC2uoWOPKGUW7W4qz6-Fh3O7cjrDucbHKD3U5hdNNvm1ywxy8x9HaT7mwjas1ZgwXe7wtM6ecMudgx5A6GwUVIc7ZMa1pjayYQffsPepvmKeL3kDJcojXqL7VxA1jcTcK-3a6ovWgY58LUUiK1_A-FZw1j6FIEHzB-lPDuIKEHN5Q-p2He7T0fg_QR7KaU8wT-aRmM2gfB2AfB2J1g7E4wmPLmcIlPCX_kIe4BdVC5rg</recordid><startdate>201703</startdate><enddate>201703</enddate><creator>Adrian, Streinu-Cercel</creator><general>Asociatia pentru Cresterea Vizibilitatii Cercetarii Stiintifice (ACVCS)</general><general>European HIV/AIDS and Infectious Diseases Academy</general><general>Asociația pentru Creşterea Vizibilității Cercetării Ştiințifice (ACVCS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6382-5067</orcidid></search><sort><creationdate>201703</creationdate><title>Consensus statement on the management of patients with HCV infection in Romania</title><author>Adrian, Streinu-Cercel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3676-6ffba8071a21103a61b791f9a172551a52fea6709b6d7317e0b8be271a91029d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Colleges & universities</topic><topic>Drug therapy</topic><topic>Evaluation</topic><topic>Hepatitis C</topic><topic>Hospitals</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Laboratories</topic><topic>Liver cancer</topic><topic>Liver diseases</topic><topic>Medical care quality</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Patients</topic><topic>Pharmacy</topic><topic>Review</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adrian, Streinu-Cercel</creatorcontrib><creatorcontrib>Consensus Statement on HCV Infection in Romania Working Group</creatorcontrib><creatorcontrib>Consensus Statement on HCV Infection in Romania Working Group</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Germs (Bucureşti)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adrian, Streinu-Cercel</au><aucorp>Consensus Statement on HCV Infection in Romania Working Group</aucorp><aucorp>Consensus Statement on HCV Infection in Romania Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Consensus statement on the management of patients with HCV infection in Romania</atitle><jtitle>Germs (Bucureşti)</jtitle><addtitle>Germs</addtitle><date>2017-03</date><risdate>2017</risdate><volume>7</volume><issue>1</issue><spage>32</spage><epage>39</epage><pages>32-39</pages><issn>2248-2997</issn><eissn>2248-2997</eissn><abstract>HCV direct-acting antivirals (DAAs) have made treatment easier for both patients and healthcare practitioners, but have also brought new challenges in terms of patient management and monitoring prior to, during, and after treatment.
To sum up and unify the clinical experience of Romanian DAA prescribing physicians, we have organized a Consensus Meeting in November 2016 in Bucharest, Romania.
The Consensus Meeting has provided expert answers to ten significant questions regarding HCV infection, namely: How do we diagnose patients with HCV infection? How do we stage liver disease in patients with HCV infection? How do we monitor patients with HCV infection prior to treatment? Which patients with HCV infection do we treat? When do we start treatment for HCV infection? What regimens do we use for treating HCV infection? How do we monitor patients with HCV infection during treatment? What adverse events should we expect during treatment of HCV infection and how do we prevent/manage them? How do we monitor patients with HCV infection after treatment? How do we expect the landscape of HCV to change in the following years?</abstract><cop>Romania</cop><pub>Asociatia pentru Cresterea Vizibilitatii Cercetarii Stiintifice (ACVCS)</pub><pmid>28331840</pmid><doi>10.18683/germs.2017.1106</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-6382-5067</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2248-2997 |
| ispartof | Germs (Bucureşti), 2017-03, Vol.7 (1), p.32-39 |
| issn | 2248-2997 2248-2997 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5348215 |
| source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Colleges & universities Drug therapy Evaluation Hepatitis C Hospitals Infections Infectious diseases Laboratories Liver cancer Liver diseases Medical care quality Medical imaging Medicine Patients Pharmacy Review Ultrasonic imaging |
| title | Consensus statement on the management of patients with HCV infection in Romania |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T13%3A17%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Consensus%20statement%20on%20the%20management%20of%20patients%20with%20HCV%20infection%20in%20Romania&rft.jtitle=Germs%20(Bucure%C5%9Fti)&rft.au=Adrian,%20Streinu-Cercel&rft.aucorp=Consensus%20Statement%20on%20HCV%20Infection%20in%20Romania%20Working%20Group&rft.date=2017-03&rft.volume=7&rft.issue=1&rft.spage=32&rft.epage=39&rft.pages=32-39&rft.issn=2248-2997&rft.eissn=2248-2997&rft_id=info:doi/10.18683/germs.2017.1106&rft_dat=%3Cgale_pubme%3EA512239466%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1892666657&rft_id=info:pmid/28331840&rft_galeid=A512239466&rfr_iscdi=true |